177 related articles for article (PubMed ID: 26967253)
1. Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer.
Sun W; Jiang YZ; Liu YR; Ma D; Shao ZM
Oncotarget; 2016 Apr; 7(15):20496-506. PubMed ID: 26967253
[TBL] [Abstract][Full Text] [Related]
2. Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer.
Li Y; Ma L
BMC Cancer; 2021 Aug; 21(1):965. PubMed ID: 34454451
[TBL] [Abstract][Full Text] [Related]
3. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
4. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
5. Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Nonmetastatic Inflammatory Breast Cancer Patients Receiving Tri-Modality Therapy: A Population-Based Study.
Huang Q; Xu TY; Wu ZY
Med Sci Monit; 2019 Dec; 25():9167-9178. PubMed ID: 31789307
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of Nomograms for Predicting Overall and Breast Cancer-Specific Survival in Young Women with Breast Cancer: A Population-Based Study.
Gong Y; Ji P; Sun W; Jiang YZ; Hu X; Shao ZM
Transl Oncol; 2018 Dec; 11(6):1334-1342. PubMed ID: 30189361
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer.
Chen MS; Liu PC; Yi JZ; Xu L; He T; Wu H; Yang JQ; Lv Q
Sci Rep; 2022 Aug; 12(1):14659. PubMed ID: 36038627
[TBL] [Abstract][Full Text] [Related]
8. Analysis of breast cancer survival in a northeastern Brazilian state based on prognostic factors: A retrospective cohort study.
Marques AD; Moura AR; Hora EC; Brito ÉAC; Oliviera LS; Feitosa IR; Freitas FF; Lima MS; de Carvalho Barreto ÍD; Santos MO; da Silva AM; Lima CA
PLoS One; 2022; 17(2):e0263222. PubMed ID: 35113931
[TBL] [Abstract][Full Text] [Related]
9. Evaluating overall survival and competing risks of survival in patients with early-stage breast cancer using a comprehensive nomogram.
Xu YB; Liu H; Cao QH; Ji JL; Dong RR; Xu D
Cancer Med; 2020 Jun; 9(12):4095-4106. PubMed ID: 32314546
[TBL] [Abstract][Full Text] [Related]
10. Association between socioeconomic factors at diagnosis and survival in breast cancer: A population-based study.
Ji P; Gong Y; Jiang CC; Hu X; Di GH; Shao ZM
Cancer Med; 2020 Mar; 9(5):1922-1936. PubMed ID: 31960597
[TBL] [Abstract][Full Text] [Related]
11. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
Wong SM; King T; Boileau JF; Barry WT; Golshan M
Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
[TBL] [Abstract][Full Text] [Related]
12. Competing Risk Analyses of Medullary Carcinoma of Breast in Comparison to Infiltrating Ductal Carcinoma.
Dai D; Shi R; Wang Z; Zhong Y; Shin VY; Jin H; Wang X
Sci Rep; 2020 Jan; 10(1):560. PubMed ID: 31953417
[TBL] [Abstract][Full Text] [Related]
13. Real-world impact of non-breast cancer-specific death on overall survival in resectable breast cancer.
Fu J; Wu L; Jiang M; Li D; Jiang T; Fu W; Wang L; Du J
Cancer; 2017 Jul; 123(13):2432-2443. PubMed ID: 28267199
[TBL] [Abstract][Full Text] [Related]
14. Construction and Validation of Nomograms Predicting Survival in Triple-Negative Breast Cancer Patients of Childbearing Age.
Cui X; Song D; Li X
Front Oncol; 2020; 10():636549. PubMed ID: 33628740
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of nomograms for predicting overall and breast cancer-specific survival among patients with triple-negative breast cancer.
Guo LW; Jiang LM; Gong Y; Zhang HH; Li XG; He M; Sun WL; Ling H; Hu X
Cancer Manag Res; 2018; 10():5881-5894. PubMed ID: 30510456
[TBL] [Abstract][Full Text] [Related]
16. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer.
Zhang J; Gong Z; Gong Y; Guo W
Jpn J Clin Oncol; 2019 May; 49(5):438-446. PubMed ID: 30924498
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast.
Cheng Y; Zhang P; Huang Y; Zhang Z; Tang R; Chi F; Sun JY; He Z
BMJ Open; 2023 Feb; 13(2):e065312. PubMed ID: 36810178
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the clinical outcomes of patients with invasive lobular carcinoma and invasive ductal carcinoma of the breast according to molecular subtype in a Korean population.
Lim ST; Yu JH; Park HK; Moon BI; Ko BK; Suh YJ
World J Surg Oncol; 2014 Mar; 12():56. PubMed ID: 24621330
[TBL] [Abstract][Full Text] [Related]
20. Establishment and Validation of Novel Clinical Prognosis Nomograms for Luminal A Breast Cancer Patients with Bone Metastasis.
Tu Q; Hu C; Zhang H; Peng C; Kong M; Song M; Zhao C; Wang Y; Li J; Zhou C; Wang C; Ma X
Biomed Res Int; 2020; 2020():1972064. PubMed ID: 33490234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
